MTS Medication Technologies (AMEX: MPP) reports Q4 EPS of $0.11, 1 cent worse than estimates. Revenues were $14.3 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE